Pharmaceutical & Regulatory Expertise

We implement robust quality initiatives and control methodologies aligned with global Health Authority expectations. Our expertise spans GxP services, clinical programs, and complex drug development environments.

Acting as trusted scientific partners, our consultants combine technical expertise, business insight, and leadership to support research, development, and market delivery.

We work closely with clients to achieve Health Authority approvals and sustain compliance across global markets.

Our experience covers non-clinical development, manufacturing, marketing authorisations, and ongoing regulatory obligations.

Expertise includes pre-approval (IND, NDA, BLA) and post-approval variations and lifecycle management.

Our clinical professionals support decision-making around trial readiness and study strategy, including advanced therapy medicinal products (ATMPs).

We help organisations transition confidently from pre-clinical development into regulated clinical trials.

We support organisations requiring MIA or WDA licences by providing experienced QP and RP oversight throughout manufacturing and distribution.

• QP/RP named on MIA or WDA licences
• Support with manufacturer and wholesale licences
• Design and maintenance of Quality Management Systems
• Flexible long-term and interim staffing models
• Dual-QP continuity to reduce operational risk
• Full QMS oversight across EU distribution channels

Our consultants apply Lean and Six Sigma principles to help build sustainable quality cultures within organisations.

Training spans theory and hands-on practice, delivering measurable operational improvements.

We collaborate closely with teams to align processes, people, and performance with long-term business objectives.

We support organisations in meeting international GMP standards through gap assessments, remediation planning, audit readiness, and ongoing compliance oversight.

Our team helps you identify gaps, build robust remediation plans, and maintain inspection readiness so you can operate with confidence across global markets.

We provide expert support to address FDA inspection findings, including 483 responses, CAPA development, remediation execution, and sustainable quality system improvements.

From drafting responses and corrective actions to implementing lasting process changes, we help you resolve findings and strengthen your quality systems for the long term.

We offer regulatory and drug representation services to help organisations manage Health Authority interactions, maintain compliance, and ensure effective product oversight in target markets.

Our representation services provide a local or regional point of contact for regulators and support compliant market presence where you need it.

Our experienced consultants provide on-site person-in-plant support to monitor operations, oversee quality activities, and ensure compliance with regulatory and client expectations.

We deliver hands-on oversight at your facilities or your partners’, helping you maintain visibility and control over critical quality and compliance activities.

We manage product complaints and healthcare professional (HCP) interactions in line with regulatory requirements, ensuring accurate documentation, timely investigations, and compliant safety reporting.

From intake and investigation through to closure and regulatory reporting, we help you meet pharmacovigilance and quality expectations while protecting patient safety.